U.S. court rules in favor of Mylan over Biogen's key MS drug patent

A U.S. district court on Thursday ruled in favor of generic drugmaker Mylan NV in a patent dispute over Biogen Inc's blockbuster multiple sclerosis drug, Tecfidera, ... Read more

Bron:

Reuters: Health News